BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • November 2026
  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

Browsing Tag

CytomX Therapeutics (NASDAQ:CTMX)

3 posts

Biotech NewsShould You Now Start Investing in CytomX Therapeutics (CTMX)?

  • BioTech Health X
  • April 18, 2026
We recently published our article Top 10 Best Biotech Microcap Stocks That Could Explode 10X in 2026. In…
0 Shares
0
0
0
0
0
0
0

Biotech NewsTop 10 Best Biotech Microcap Stocks That Could Explode 10X in 2026

  • BioTech Health X
  • April 11, 2026
In this article, will take a look at the Top 10 Best Biotech Microcap Stocks That Could Explode…
0 Shares
0
0
0
0
0
0
0

Biotech NewsCytomX (CTMX) Boosts Cash to $158.1M After $100M Raise

  • BioTech Health X
  • September 15, 2025
CytomX Therapeutics Inc. (NASDAQ:CTMX) is a clinical-stage biotechnology company dedicated to transforming the treatment of cancer through its…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • Johnson & Johnson (JNJ) Flexes Its Oncology Muscle With 16.4% Sales Growth
  • Would You Still Dare to Invest in Revolution Medicines (RVMD)?
  • Merck (MRK) Has an $8.6 Billion Cancer Franchise and a Succession Plan to Prove
  • AbbVie (ABBV) Delivers $17.4 Billion in Revenue
  • Pfizer (PFE) Gets an Oncology Boost as Padcev Sales Surge 55%
Featured Posts
    • November 6, 2026
    Johnson & Johnson (JNJ) Flexes Its Oncology Muscle With 16.4% Sales Growth
    • November 6, 2026
    Would You Still Dare to Invest in Revolution Medicines (RVMD)?
    • November 6, 2026
    Merck (MRK) Has an $8.6 Billion Cancer Franchise and a Succession Plan to Prove
    • November 6, 2026
    AbbVie (ABBV) Delivers $17.4 Billion in Revenue
    • November 6, 2026
    Pfizer (PFE) Gets an Oncology Boost as Padcev Sales Surge 55%
Recent Posts
  • Guardant Health (GH) Posts 44% Revenue Growth as Liquid Biopsy Gains Ground
    • November 6, 2026
  • Natera (NTRA) Gets a Growth Spurt as Cancer Testing Volume Jumps 57%
    • November 6, 2026
  • Is it Still a Wise Move to Invest in Cogent Biosciences (COGT)?
    • November 6, 2026
Categories
  • BioTech CEO Interviews (9)
  • Biotech Info (6)
  • Biotech News (1,185)
  • Uncategorized (2)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top